Xilio Therapeutics Inc (XLO) Price Prediction & ForecastXLOXilio Therapeutics Inc

Alphio's XLO stock price prediction model matches the current Xilio Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.03 (+0.36%). The 1-week path is $9.04 (+0.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Xilio Therapeutics Inc is currently not a strong buy due to its recent performance and financial instability. The stock closed at $9.00, with a 5-day change of -2.49% and a year-to-date change of -4.29%. While there is potential for future growth, as indicated by a projected trajectory of +931.59%, the current RSI of 30.047 suggests the stock is oversold, which could indicate a potential rebound. However, the main risk is the negative net income reported for Q1 2026 at -$9.5 million, which reflects ongoing financial challenges.

Xilio Therapeutics Inc (XLO) last closed at $9, losing -0.11%. These facts feed the 1-day and 1-week XLO price prediction above.